MedPath

Lek Pharmaceuticals dd

🇸🇮Slovenia
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.lek.si

Clinical Trials

1

Active:0
Completed:1

Trial Phases

0 Phases

Drug Approvals

86

PHILIPPINES:49
NMPA:30
SFDA:7

Drug Approvals

Mometasone Furoate Aqueous Nasal Spray

Product Name
糠酸莫米松鼻喷雾剂
Approval Number
国药准字HJ20220085
Approval Date
Nov 15, 2022
NMPA

Mometasone Furoate Aqueous Nasal Spray

Product Name
糠酸莫米松鼻喷雾剂
Approval Number
国药准字HJ20220084
Approval Date
Nov 15, 2022
NMPA

Rosuvastatin Calcium Tablets

Product Name
瑞舒伐他汀钙片
Approval Number
国药准字HJ20191004
Approval Date
Oct 25, 2022
NMPA

Rosuvastatin Calcium Tablets

Product Name
瑞舒伐他汀钙片
Approval Number
国药准字HJ20180008
Approval Date
Oct 25, 2022
NMPA

Rosuvastatin Calcium Tablets

Product Name
瑞舒伐他汀钙片
Approval Number
国药准字HJ20180007
Approval Date
Oct 25, 2022
NMPA

Rosuvastatin Calcium Tablets

Product Name
瑞舒伐他汀钙片
Approval Number
国药准字HJ20191003
Approval Date
Oct 25, 2022
NMPA

Escitalopram Oxalate Tablets

Product Name
草酸艾司西酞普兰片
Approval Number
国药准字HJ20220003
Approval Date
Jan 30, 2022
NMPA

Amoxicillin Sodium and Clavulanate Potassium for injection

Product Name
莱得怡
Approval Number
国药准字HJ20120196
Approval Date
Jul 22, 2021
NMPA

Amlodipine Besylate Tablets

Product Name
苯磺酸氨氯地平片
Approval Number
国药准字HJ20171119
Approval Date
May 17, 2021
NMPA

Amlodipine Besylate Tablets

Product Name
苯磺酸氨氯地平片
Approval Number
国药准字HJ20150008
Approval Date
May 17, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.